Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q2 2026 vs. Q1 2026
How the institutions holding Novo Nordisk A S changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 3 | 3 | 0 |
| Shares | 90.3K | 111.4K | +21.1K (+23.3%) |
| Value | $13.9M | $5.36M | −$8.57M (−61.5%) |
New holders (0)
Institutions that held Novo Nordisk A S at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (0)
Institutions that held Novo Nordisk A S at the end of Q1 2026 and filed for Q2 2026 without it.
None.